School of Pharmacy - News

Increased consumption of whole grain foods could significantly reduce the incidence of type 2 diabetes and the costs associated with its treatment in Finland, according to a recent study.

University of Eastern Finland really sweeps you into the world of toxicology in an intriguing way, says Emma Tarvainen, UEF Alumni.

Obesity is associated with many comorbidities, including non-alcoholic fatty liver disease. Scientists provided novel insight into how specific drug transporters associate with such chronic liver conditions and may modulate drug distribution, efficacy, and safety.

The Frontiers in Health Sciences seminar series will continue in October–December 2021 with online lectures by leading Finnish scientists. The lectures are open to all.

Chronically elevated blood insulin levels, or hyperinsulinemia, leads to premature senescence of human mature adipocytes and production of pro-inflammatory adipokines, according to a new study.

The Nordic POP and FinPharmaNet joint meeting was a great success, with high online turnout, top-notch speakers, and an engaged audience.

In the future, a growing number of neurodegenerative diseases could ideally be treated with the same drug, says Timo Myöhänen, the University of Eastern Finland’s newly appointed Professor of Pharmacology and Drug Development.

Nuclear receptors are transcription factors, which regulate gene expression in response to ligand binding, a feature which makes them ideal drug targets.

The doctoral thesis of Rami El-Dairi, MSc, provides novel information about placental gene expression and insights into how chemicals may disrupt normal placental physiological functions in pregnant women.

Researchers at UEF's School of Pharmacy and the Finnish Institute for Health and Welfare have received a grant of 400,000 US dollars from The Michael J. Fox Foundation.